Perfuse Therapeutics has reported 24-week data from its first-in-human, multi-centre Phase I/IIa trial of the PER-001 intravitreal implant for individuals with glaucoma. The trial of PER-001 is ...

Hexiris’ patented ocular implant represents a revolutionary advancement in glaucoma treatment, being the first injectable ocular implant that can be delivered under a standard office slit lamp ...

Credit: elenavolf / Shutterstock. Perfuse Therapeutics has reported 24-week data from its first-in-human, multi-centre Phase I/IIa trial of the PER-001 intravitreal implant for individuals with ...

This trial provides the first clinical validation of the key role of endothelin pathway in glaucoma. The results of this trial are highly encouraging and the data supports the potential of PER-001 ...

Patients in the study — 95% of whom originally received an Ahmed glaucoma valve — underwent cyclophotocoagulation, a laser procedure that treats glaucoma by reducing fluid production in the eye ...

“Previous studies have provided evidence of outcome disparities following glaucoma surgery between the two populations and higher rates of treatment failure in African American patients, complicating ...

and previous glaucoma surgeries were collected for each patient preoperatively. The desired quadrant, type of patch graft, and tube position of the surgery were also noted. Follow-up visits were ...

Purpose: The Ahmed FP-7 valve is useful in the management of refractory glaucoma. However, this can often have ocular ... The functionality of the implant was confirmed by allowing the BSS to flow ...

[35–38] There are a number of synonyms for aqueous shunts including glaucoma drainage devices, tube implants, and tube shunts. Devices available in the United States include the Ahmed (12 models ...